SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (5742)12/7/1998 7:21:00 PM
From: John Metcalf   of 6136
 
Hi, Rick. Not sure I understand the poll. Does "eat" mean to devour utterly or degustate? -:)

The larger biotechs have fared well in the last quarter. As number 12 in market cap amongst biotechs, AGPH is the kind of company that has attracted attention. Accordingly, short interest dropped 19% in October, and 2% more in November reports.

AGPH still has head room, with a very low price to sales ratio (3:1) for a top twelve biotech.

I'll have to go with "D) all of the above". Applauding success is much better than whining -:)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News